Role of priority setting in implementing universal health coverage

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i244 (Published 26 January 2016) Cite this as: BMJ 2016;352:i244
  1. Yot Teerawattananon, programme leader1,
  2. Alia Luz, project associate2,
  3. Churnrurtai Kanchanachitra, director, Mahidol University Global Health3,
  4. Sripen Tantivess, senior researcher1
  5. On behalf of the Prince Mahidol Award Conference secretariat
  1. 1Health Intervention and Technology Assessment Program (HITAP), Thailand
  2. 2HITAP International Unit, Ministry of Public Health, Mueang, Nonthaburi 11000, Thailand
  3. 3Mahidol University, Salaya, Thailand
  1. Correspondence to: A Luz alia.l{at}hitap.net

Explicit, evidence based priorities are essential for efficient use of resources

When is a country financially ready to implement universal health coverage (UHC), a health policy designed to ensure that all citizens receive the health services they need without financial hardship?1 Since no standard set of essential health services or a defined benefits package for universal coverage exists, determining financial readiness is challenging. Health priorities must be set knowing what services are to be provided, to whom they will be provided, and how.

Priority setting helps determine the financial requirements for UHC, and thus the financial capacity of a country to adopt it. Setting priorities also helps decide on the benefits package that is feasible given current resource constraints. Countries can deliver a limited benefits package and identify priorities for expansion should additional resources become available. In either scenario, priority setting is essential for any country committed to universal coverage.

Priority setting can be explicit or implicit. Governments should favour explicit rationing, wherein the decisions and their justifications are clear, rather than strategies of implicit rationing such as denial, deterrence, deflection, delay, and dilution.2 In 2015, the UN General Assembly made a global commitment to UHC and the sustainable development goals.3 4 As such, more emerging economies will commit to UHC. Explicit priority setting, however, requires dedicated resources, which are more readily available in wealthier countries.

In 1912, Norway was the first country to introduce UHC. Several other high income countries followed, but 64 years passed before Cuba became the first middle income country to introduce UHC legislation in 1976. By 2015, 58 countries had achieved universal coverage, of which 22 did so while they were low or middle income countries (LMICs). 5 Thus, the challenge that remains is supporting countries with limited capacity to implement UHC and set priorities explicitly.

Health priority setting in support of UHC requires capacity and resources, as well as persuasive evidence to justify decisions (figure).6 This involves two major steps: evidence generation and use of evidence in resource allocation, programme management, and quality assurance. Priority setting in health systems is complicated by a wide range of political, economic, ethical, and sociocultural factors.7 An explicit process requires four building blocks (box).


Framework for evidence informed priority setting

Four building blocks for effective priority setting

  • Governing structure with clear functions and regulation of institutes and their inter-relations

  • Resource availability and mobilisation to support priority setting

  • Capacity building programmes for better understanding of health priority setting by policy makers, researchers, and other stakeholders, including the general public

  • Collaboration with networks of local, international, and global organisations that aim to support UHC policies.

Evidence generation, either from academically rigorous research or from relatively simpler analyses of data, requires skilled workers, reliable and up-to-date data and information systems, rigorous methods, and pragmatic approaches. For example, health technology assessment is recognised as a useful tool for setting priorities for biomedical and public health interventions.8 But generation of evidence does not guarantee it will be acted on. The connection between evidence, priority setting, and policy making is influenced by politics and shaped by social values such as efficiency, equity, morality, and solidarity as well as various competing interests9—for example, those of society, health purchasers, providers, professionals, drug companies, and device manufacturers.10

In practice, setting health priorities in most LMICs is imperfect because of constraints in the four building blocks. Importantly, inadequate governance impairs resources, system capacity, and support from other organisations. These issues allow powerful vested interests, such as industry and health professionals,11 12 to dominate both the technical and political aspects of priority setting. Subsequently, the quality of evidence is undermined, as is political commitment to using evidence to inform decision making, disinvestment, programme design, and formulation of guidelines for UHC.13

UHC is not only about financial readiness; it also requires good governance in allocating finite resources and ensuring health and equity. The Prince Mahidol Award Conference on 26-31 January 2016, in Bangkok, Thailand, will discuss the Bangkok statement, which aims to garner commitment and provide guidance to develop fair, transparent, systematic, and evidence based priority setting processes to support achievement of the goals of UHC. We welcome your comments on our draft proposals available at the conference website (www.pmaconference.mahidol.ac.th/index.php?option=com_content&view=article&id=758&Itemid).

Sufficient finances have the potential to improve infrastructure, provision of health services, and availability of human resources, but they do not guarantee good governance and efficient use of resources. This is the important role of priority setting in implementing universal health coverage.


Cite this as: BMJ 2016;352:i244


  • Competing interests: We have read and understood BMJ policy on declaration of interests and declare the following: CK is part of the conference secretariat, and HITAP works as a technical lead for the planning of the conference. However, the authors did not have financial support for writing this editorial. HITAP’s International Unit was established with support from the Thai Health-Global Link Initiative Project (TGLIP), the international Decision Support Initiative (iDSI) funded by the Bill and Melinda Gates Foundation and the UK Department of International Development, and the Rockefeller Foundation to provide technical assistance on health intervention and technology assessment for governments of low and middle income countries. The editorial does not necessarily reflect the views of these agencies.

  • Provenance and peer review: Commissioned; not externally peer reviewed.


View Abstract